Reported Reactions

Devices › Prosthesis, breast, noninflatable, internal, silicone gel-filled

Device brand name · Prosthesis breast noninflatable internal silicone gel-filled

Inspira Textured Silicone Gel Filled Breast Implant: medical device reports filed with FDA

24,795 reports name it, 2015–2026. Manufacturer given most often on reports: Allergan Costa Rica. Product code FTR.

24,795
device reports naming the brand
0.1% of all MAUDE reports · about 2,188 a year
2,766
reports, 12 months to August 2026
2,960 in the 12 months before
0.1%
classified as malfunction
1.6% across the product code
0%
classified as death, as reported
1 reports · not verified by FDA

24,795 medical device reports received by FDA name the brand "Inspira Textured Silicone Gel Filled Breast Implant" (prosthesis breast noninflatable internal silicone gel-filled); the manufacturer given most often on reports is Allergan Costa Rica; received from March 2015 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

2,766 reports arrived in the 12 months to August 2026, close to the 2,960 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and malfunction (0.1%); across all prosthesis, breast, noninflatable, internal, silicone gel-filled reports (product code FTR) death is recorded in 0.1% and malfunction in 1.6%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are material rupture (59.8%), device appears to trigger rejection (32.4%) and patient-device incompatibility (11.2%). The patient problems coded most often are failure of implant, capsular contracture and seroma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0211421Sep 2021: 206Oct 2021: 174Nov 2021: 279Dec 2021: 2202022Jan 2022: 239Feb 2022: 270Mar 2022: 361Apr 2022: 313May 2022: 338Jun 2022: 325Jul 2022: 287Aug 2022: 378Sep 2022: 289Oct 2022: 322Nov 2022: 421Dec 2022: 4092023Jan 2023: 237Feb 2023: 354Mar 2023: 359Apr 2023: 305May 2023: 228Jun 2023: 295Jul 2023: 276Aug 2023: 270Sep 2023: 226Oct 2023: 325Nov 2023: 326Dec 2023: 2352024Jan 2024: 287Feb 2024: 271Mar 2024: 304Apr 2024: 268May 2024: 276Jun 2024: 248Jul 2024: 312Aug 2024: 290Sep 2024: 244Oct 2024: 257Nov 2024: 227Dec 2024: 2362025Jan 2025: 225Feb 2025: 261Mar 2025: 235Apr 2025: 272May 2025: 225Jun 2025: 274Jul 2025: 292Aug 2025: 212Sep 2025: 237Oct 2025: 244Nov 2025: 242Dec 2025: 2562026Jan 2026: 202Feb 2026: 260Mar 2026: 215Apr 2026: 211May 2026: 224Jun 2026: 213Jul 2026: 227Aug 2026: 235

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01,9763,9522015: 320152016: 52017: 8720172018: 1512019: 2,76220192020: 3,4942021: 2,92320212022: 3,9522023: 3,43620232024: 3,2202025: 2,97520252026: 1,787

Event type and report source

Event type, as classified on the report

Death0%1
Injury99.9%24,770
Malfunction0.1%24
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%24,795
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 231,877 reports carrying product code FTR. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Material rupture14,82059.8%42.7%
Device appears to trigger rejection8,02732.4%21.6%
Patient-device incompatibilitythe device did not suit the patient2,78511.2%6.6%
Migrationthe device moved from where it was placed1,0584.3%2.4%
Gel leak2190.9%1.9%
Malposition of device550.2%0.5%
Fluid/blood leak360.1%0.2%
Material invagination340.1%0%
Breakthe device broke270.1%0.5%
Improper or incorrect procedure or method200.1%0.1%
Device handling problem190.1%0.2%
Material deformation110%0.2%
Migration or expulsion of device100%0.2%
Insufficient device problem information70%0.2%
Off-label use60%0.1%
Material integrity problema problem with the device material50%0%
Device dislodged or dislocated40%0%
Biofilm coating in device30%0%
Deformation due to compressive stress30%0%
Biocompatibility20%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant10,85343.8%
Capsular contracturescar tissue tightening around an implant10,76243.4%
Seromaa collection of fluid under the skin4,41017.8%
Swollen lymph nodes/glands1,1084.5%
Granuloma8283.3%
Swollen lymph nodes2581%
Lymphomaa cancer of the lymphatic system2120.9%
Breast implant associated anaplastic large cell lymphoma (bia alcl)1100.4%
Appropriate clinical signs, symptoms and conditions term/code not available990.4%
Painpain, site not specified890.4%
Inflammationinflammation830.3%
Necrosisdeath of tissue650.3%
Breast mass590.2%
Wound dehiscencea wound reopened530.2%
Breast discomfort/pain490.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureInspira Textured Silicone Gel Filled Breast ImplantProduct code FTRAll MAUDE reports
Reports24,795231,87726,136,888
Share of that pool—10.7%0.1%
Classified as death, per 1,000 reports019
Classified as injury99.9%97.7%36.2%
Classified as malfunction0.1%1.6%62.3%
Filed by the manufacturer100%95%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FTR

BrandReportsLatest 12 monthsClassified as death
MENTOR MemoryGel Breast Implant57,7717,7080%
Inspira Smooth Silicone Gel Filled Breast Implant35,6346,7820%
Style 410 Cohesive Silicone Gel Filled Breast Implant15,2871,8410.1%
Style 15 Silicone Gel Filled Breast Implant9,5671,5290.1%
Style 20 Silicone Gel Filled Breast Implant6,3689810.1%
Sientra Silicone Gel Breast Implants6,0141,6820%
Style 115 Silicone Gel Filled Breast Implant5,7105460%
Unknown Gel Implants5,3377030%
UNK Gel Breast Implant5,3027820.4%
MENTOR MemoryGel Xtra Breast Implant4,9101,3870%
Inspira Smooth Cohesive Silicone Gel Filled Breast Implant4,6361,0760%
Sientra Opus Silicone Gel Breast Implant4,61300%
Style 110 Silicone Gel Filled Breast Implant3,3642790%
Style 10 Silicone Gel Filled Breast Implant3,3534790.1%
Style 120 Silicone Gel Filled Breast Implant2,8812120.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Inspira Textured Silicone Gel Filled Breast Implant reports

How many FDA reports name Inspira Textured Silicone Gel Filled Breast Implant?

24,795 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 2,766 in the latest 12 months.

What kinds of events are reported?

injury (99.9%) and malfunction (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

material rupture (59.8%), device appears to trigger rejection (32.4%), patient-device incompatibility (11.2%), migration (4.3%) and gel leak (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Inspira Textured Silicone Gel Filled Breast Implant was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.